POLYDOPAMINE/POLY(SULFOBETAINE METHACRYLATE) CO-DEPOSITION COATINGS TRIGGERED BY CUSO4/H2O2 ON IMPLANTS FOR IMPROVED SURFACE HEMOCOMPATIBILITY AND ANTIBACTERIAL ACTIVITY

Polydopamine/poly(sulfobetaine methacrylate) Co-deposition coatings triggered by CuSO4/H2O2 on implants for improved surface hemocompatibility and antibacterial activity

Polydopamine/poly(sulfobetaine methacrylate) Co-deposition coatings triggered by CuSO4/H2O2 on implants for improved surface hemocompatibility and antibacterial activity

Blog Article

Implanted biomaterials such as medical catheters are prone to be adhered by proteins, platelets and bacteria due flex 4 heartworm test to their surface hydrophobicity characteristics, and then induce related infections and thrombosis.Hence, the development of a versatile strategy to endow surfaces with antibacterial and antifouling functions is particularly significant for blood-contacting materials.In this work, CuSO4/H2O2 was used to trigger polydopamine (PDA) and poly-(sulfobetaine methacrylate) (PSBMA) co-deposition process to endow polyurethane (PU) antibacterial and antifouling surface (PU/PDA(Cu)/PSBMA).The zwitterions contained in the PU/PDA(Cu)/PSBMA coating can significantly improve surface wettability to reduce protein adsorption, thereby improving its blood compatibility.

In addition, the copper ions released from 15-eg1053cl the metal-phenolic networks (MPNs) imparted them more than 90% antibacterial activity against E.coli and S.aureus.Notably, PU/PDA(Cu)/PSBMA also exhibits excellent performance in vivo mouse catheter-related infections models.

Thus, the PU/PDA(Cu)/PSBMA has great application potential for developing multifunctional surface coatings for blood-contacting materials so as to improve antibacterial and anticoagulant properties.

Report this page